Associated Papers
Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024.
Vukovikj M et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 2025
40084420 (PubMed )
Supplement: 24-00252_BROBERG_Supplement.pdf
First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
Colson P et al.
Journal of Medical Virology, 2022
Select a paper to view details